February 2026 brought a wave of GLP-1 developments relevant to providers running or building a medical weight loss practice — from the expanding oral treatment landscape and a tightening regulatory environment around compounded alternatives, to new clinical evidence on nutritional deficiencies and muscle loss in long-term users. This month’s update covers what the research says and what it means for how you structure and deliver care.